Valérie Jahns

Title: Valérie Jahns: Innovator in Cyclopeptide-Mutants

Introduction

Valérie Jahns is a prominent inventor based in Würzburg, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of novel cyclopeptide-mutants. With a total of 4 patents to his name, Jahns continues to push the boundaries of scientific innovation.

Latest Patents

His latest patents focus on the creation of novel β-AR homologous cyclopeptide-mutants. These mutants comprise only two cysteine residues that can form an intramolecular linkage. Additionally, he has developed linear peptides that can form these cyclopeptide-mutants, along with nucleic acid molecules encoding them. His inventions also include vectors and recombinant host cells that utilize these nucleic acid molecules. Furthermore, Jahns has explored therapeutic and diagnostic applications for these peptides, particularly in detecting and inhibiting anti-β1-adrenergic receptor antibodies. His work addresses various cardiac conditions, including infectious and non-infectious heart diseases, ischemic heart disease, and cardiac arrhythmias.

Career Highlights

Valérie Jahns has been associated with prestigious institutions such as Julius-Maximilians-Universität Würzburg. His research has significantly advanced the understanding of cyclopeptide-mutants and their applications in medicine.

Collaborations

He has collaborated with notable colleagues, including Roland Jahns and Martin Lohse, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Valérie Jahns stands out as a key figure in the development of innovative cyclopeptide-mutants, with a focus on therapeutic applications for cardiac conditions. His work continues to inspire advancements in biochemistry and medicine.